chrisvoncsefalvay/vaers-outcomes huggingface dataset:
aches in both shoulders, left wrist and right knee; JOINT PAIN PERSISTING; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (aches in both shoulders, left wrist and right knee) and ARTHRALGIA (JOINT PAIN PERSISTING) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011M20A and 031B21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, AMLODIPINE, LISINOPRIL, DABIGATRAN ETEXILATE MESILATE (PRADAXA) and PRAZOSIN for an unknown indication.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced ARTHRALGIA (aches in both shoulders, left wrist and right knee). 12-Mar-2021, the patient experienced ARTHRALGIA (JOINT PAIN PERSISTING). At the time of the report, ARTHRALGIA (aches in both shoulders, left wrist and right knee) and ARTHRALGIA (JOINT PAIN PERSISTING) outcome was unknown. Not Provided          TREATMENT MEDICATION TYLENOL WAS USED
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 35-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Dec2021 as dose 2, single (Lot number: FL3197) at the age of 35 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.
Patient was given vaccine 2 weeks before it was suppose to be given for the 2nd booster. It was suppose to be administered on or after 8/5/22.
rash in both arms; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number 453LA, expiry date 18th February 2022) for prophylaxis.   On 5th December 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was recovered/resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix and experienced a rash in both arms which lasted several days. Reporter consented to follow up.
p/vax pt devel a hugh cellulitis @ the site of inj very tender to touch;
I woke up at 1am the next morning very sick. I had a fever of 101, body aches, chills, nausea, vomiting, headache, dizzy, and just felt absolutely horrible.  I kept getting a strange tingly feeling that would start in my scalp and go down to my toes every now and then. Injection site has a big round red mark that?s hot and swollen.
This case was reported by a consumer and described the occurrence of irritability in a 9-month-old male subject who was vaccinated with Hepatitis A vaccine (manufacturer unspecified). A physician or other health care professional has not verified this report. Concurrent medical conditions included ear infection. Previous and/or concurrent vaccination included influenza virus vaccine; unk manufacturer; unknown given on 12 October 2010. Concurrent medications included Amoxicillin. On 12 October 2010 at 12:00 the subject received 1st dose of Hepatitis A vaccine (unknown, right thigh). On 12 October 2010, the subject was administered Hepatitis A vaccine instead of Hepatitis B vaccine and experienced wrong vaccine administered. On 13 October 2010, one day after vaccination with Hepatitis A vaccine, the subject experienced irritability. The reporter, who was the subject's mother, was uncertain of the brand of Hepatitis A that her child received. A healthcare provider was consulted regarding the event. At the time of reporting the outcome of the irritability was unspecified.
Mom stated cryin "non stop" (started 18 hrs. after vaccinations) and cont. all day and not napping well (lasting about 32 hrs now).  Once done feeding would go right back to crying. Inconsolable otherwise.  no fever. No reaction to 2mo. shots. NKDA.
Fever of 101, headache, and lump underneath left armpit. Armpit is swollen and when I press down, I feel a lump that moves around when I put pressure.
Sore arm within a few minutes. Headache, tired, nausea, unable to focus, sore arm and low fever (99.9) the next morning starting at 7:00 am but headache, fatigue and nausea worsened through the morning.
Myalgia, Fever, Diarrhea & NauseaVomiting Narrative: DOSE 2-DAY 1 PAIN AT INJ SITE; DAY 1-2-CHILLS FEVER MYALGIA NAUSEA DIARRHEA FATIGUE
Chills; Extreme Fatigue; Neuropathic pain that moves around; Stomach also became upset; Cannot eat anything without discomfort; High degree of nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Extreme Fatigue), NEURALGIA (Neuropathic pain that moves around), ABDOMINAL DISCOMFORT (Stomach also became upset) and EATING DISORDER (Cannot eat anything without discomfort) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (NO medical history).    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), FATIGUE (Extreme Fatigue), NEURALGIA (Neuropathic pain that moves around), ABDOMINAL DISCOMFORT (Stomach also became upset), EATING DISORDER (Cannot eat anything without discomfort) and NAUSEA (High degree of nausea). At the time of the report, CHILLS (Chills), FATIGUE (Extreme Fatigue), NEURALGIA (Neuropathic pain that moves around), ABDOMINAL DISCOMFORT (Stomach also became upset), EATING DISORDER (Cannot eat anything without discomfort) and NAUSEA (High degree of nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication and treatment provided
Mom states that day of vaccines given 03/07 patient started getting fussy and this was unusual for the patient. Seizure episodes began on 03/11 was taken to ER where he was then transferred to Medical Center where multiple episodes were recorded, pt was put on keppra.
Site: Redness at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild
tongue numbness, treated with benadryl 50mg IM x1.  Tolerated well, VSS
pt recv vax 14NOV97 & 19NOV97 pt exp fever of 99.4, inj site swelling, redness, & heat & congestion of the head & chest;pt felt like was hit by truck;to MD;throat red & postnatal drip;exp cough dx resp infect;
In addition to expected side effects of fever, chills, headache, body aches, pain and warmth at the injection site, and diarrhea and nausea, employee also had joint pain in shoulder and neck on left side, pain in elbow and wrist and itching and burning in feet.  Pain in lower lumbar region of back, SOB.
Frequent severe migraine attacks (only one previous severe migraine attack more than 3 years ago) starting after 1/4/21 that have not yet resolved. 4 urgent care visits, 1 ER visit, chiropractor office visits, and neurologist visit. Currently taking 1000mg Magnesium/day, 60mg ER propranolol, PRN tramadol, PRN PO toradol, PRN ondansetron, PRN promethazine (oral and suppository), PRN sumatriptan 100mg tablets. Took two different 5-day steroid bursts both not resolving migraine (5 days of prednisone  (20mg 2x/day) starting Jan 15th, 5 days of Dexamethasone starting Jan 22nd (4mg 2x/day). Still continuing care and seeking treatment for migraines (today 2/10/21)
several days p/vax had a rash in mouth, mouth was inflammed & red & pt was unable to drink from bottle; mom stated that rash was present prior vax administration;
Information has been received from a nurse practitioner concerning an 11 year old female who on 25-JUL-2007 was vaccinated with a dose of Gardasil (lot# unknown) 0.5 mL injection.  There was no concomitant medication.  On 25-JUL-2007 the patient felt dizzy after receiving Gardasil.  Medical attention was sought.  The patient laid down for a "few minutes" and felt better.  Subsequently, on 25-JUL-2007 the patient recovered from feeling dizzy.  No further information was provided.  Additional information has been requested.  This report is one of two reports.
This case was reported by a consumer via call center representative and described the occurrence of seizure in a 6-month-old female patient who received PEDIARIX (batch number FF723, expiry date unknown). On 21st November 2013, the patient received the 1st dose of PEDIARIX (intramuscular) .5 ml. On 21st November 2013, less than a day after receiving PEDIARIX, the patient experienced injection site rash and injection site erythema. On 22nd November 2013, the patient experienced crying, fontanel bulging and fever. On 23rd November 2013, the patient experienced weakness, behavior abnormal, communication disorder, difficulty sleeping and yeast infection. On 28th November, the patient experienced diaper rash and eating disorder. On 29th November 2013, the patient experienced seizure (serious criteria GSK medically significant), ear infection, sore throat and diarrhea. On 18th December 2013, the patient experienced restlessness, acne and skin eruption. On 1st March 2016, the patient experienced eczema and food allergy. PEDIARIX was discontinued (Dechallenge was unknown). Rechallange with PEDIARIX was unknown. In November 2014, the outcome of the injection site rash and injection site erythema were recovered/resolved. On an unknown date, the outcome of the seizure, crying, fontanel bulging, weakness, behavior abnormal, communication disorder, difficulty sleeping, yeast infection, diaper rash, eating disorder, ear infection, sore throat, diarrhea, restlessness, acne, skin eruption, eczema, food allergy and fever were unknown. It was unknown if the reporter considered the seizure, injection site rash, injection site erythema, crying, fontanel bulging, weakness, behavior abnormal, communication disorder, difficulty sleeping, yeast infection, diaper rash, eating disorder, ear infection, sore throat, diarrhea, restlessness, acne, skin eruption, eczema, food allergy and fever to be related to PEDIARIX. Additional details were provided as follows: The patient was administered PEDIARIX in the left thigh. On 22nd November 2013, 1 day after receiving vaccination, the patient experienced crying, fontanel bulging and fever and body temperature was recorded as 103 degree. On 23rd November 2013, 2 days after receiving vaccination, the patient experienced weakness, behavior abnormal, communication disorder, difficulty sleeping and yeast infection. On 28th November 2013, 7 days after receiving vaccination, the patient experienced diaper rash and eating disorder. On 29th November 2013, 8 days after receiving vaccination, the patient experienced seizure (serious criteria GSK medically significant), ear infection, sore throat and diarrhea. On 18th December 2013, 27 days after receiving vaccination, the patient experienced restlessness, acne and skin eruption. On 1st March 2016, 831 days after receiving vaccination, the patient experienced eczema and food allergy.
Patient received vaccination.  Walked to observation area and fell to the floor.  Remembers feeling anxious and warm and also reports history of high blood pressure and anxiety.  Patient alert and orientated in EMS room on exam.  Reports not eating.  Blood pressure 130/90, O2 97% and pulse 65.  No history of seizures.  Possibly hit his head.  Pupils equal and reactive.  Refused an ice pack and refused any further medical care including EMS.  Will follow up with primary care provider.  Water and snack provided.
PRESENTED WITH SIGNS/SYMPTOMS CORRELATED WITH VESTIBULAR HYPOFUNCTION ON THE LEFT MOST POSSIBLY CORELATED WITH L VESTIBULAR NEURITIS.
After getting Flu shot on Friday (11/14/14), I got muscle pain on my left arm (where I got the shot). On the following day, started to numbness on my face (left side), left leg and foot, left eye and head.
Information has been received from a physician concerning a patient who in approximately 2007, "about three years ago" was vaccinated with a 0.65 mL dose of ZOSTAVAX (Merck) (lot number not reported). In approximately 2010, "about three years after receiving ZOSTAVAX (Merck), the patient developed a very bad case of the shingles on her torso. The patient sought unspecified medical attention. At the time of reporting, the patient's outcome was unknown. Follow-up information has been received from a physician, concerning a 63 year old female patient with migraines, osteoporosis, gastroesophageal reflux disease (GERD), vitamin D deficiency, and a history of chickenpox in 1961 and a tumor-associated mononuclear leukocytes (TAML), who on 11-OCT-2006, was vaccinated in the left arm with an "usual" 0.65 mL dose of ZOSTAVAX (Merck) (route not reported) (lot number 652965/0622F). Concomitant therapy included codeine, DEMEROL, and sulfa (unspecified). On 21-FEB-2010, the patient developed a vesicular herpes zoster rash, whose dermatomes were from T6 group, numerous in amount (reported as "too numerous to count" (TNTC)), and distribution described as entire T6 dermatome on the right side and not located at the site of injection. Maximum corporal temperature and other systemic symptoms were not reported. It was also reported that patient had not a recent exposure to chickenpox. At the time of reporting, the patient's outcome was unknown, as it was stated that the patient had a high risk for post-herpetic neuralgia due to the severity of lesions. Follow up information has been received from a physician who indicated that the patient was vaccinated SC with a first dose of ZOSTAVAX (Merck). On 21-FEB-2010 the patient developed severe case of shingles, "now" with post herpetic neuralgia. The patient required Emergency room/Doctor visit. At the time of the report, the patient had not recovered. The reporting physician considered very bad case of shingles and post herpetic neuralgia to be disabling. Additional information is not expected.
Before the period starts, she had severe abdominal pain. She had to take pain killer to relieve the pain.; Flu like symptoms; Muscle pain; Joint pain; Headache; Heart palpitation; She started having her period, which includes excessive bleeding and clotting; This spontaneous case was reported by a consumer and describes the occurrence of ARRHYTHMIA (Heart palpitation) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 036C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Apr-2021, the patient experienced HEAVY MENSTRUAL BLEEDING (She started having her period, which includes excessive bleeding and clotting). On 29-Apr-2021, the patient experienced ARRHYTHMIA (Heart palpitation) (seriousness criterion medically significant), ABDOMINAL PAIN (Before the period starts, she had severe abdominal pain. She had to take pain killer to relieve the pain.), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), HEADACHE (Headache) and INFLUENZA LIKE ILLNESS (Flu like symptoms). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, ARRHYTHMIA (Heart palpitation), HEAVY MENSTRUAL BLEEDING (She started having her period, which includes excessive bleeding and clotting), ABDOMINAL PAIN (Before the period starts, she had severe abdominal pain. She had to take pain killer to relieve the pain.), MYALGIA (Muscle pain), ARTHRALGIA (Joint pain), HEADACHE (Headache) and INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       She took Tylenol, which did not  work before taking Ibuprofen.  No concomitant medication information was provided.   This case was linked to MOD-2021-187152 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Fever, chills, sore throat, cough, achiness (muscle soreness), fatigue, nasal congestion, vomiting and diarrhea lasting for 4 days.  Covid positive at home, at physician's office on 7/1/22 then at home on day 5, day 7, day 10, day 11 and day 12.  Negative on day 13.
Extreme muscle aches and pain.  Not just muscle aches at location of injection but all over.
Extremely sore neck and horrible headache and spine pain.  My brain felt inflamed and I was not able to function cognitively.  I should have called 911 or gone to hospital but I was so confused I didn?t understand what I needed to do and the only other people in my house were my dependents.  I fell asleep frequently and my child could not rouse me.  My daughter was afraid I was dying or completely suddenly senile.  Extremely dizzy and unable to figure out how to complete daily tasks.  It felt like I was under water.  Symptoms began to improve 4/6/21.   I did not see a doctor because I was unable to figure out how to do that at the time.  I had a hard time communicating with my children and would become extremely confused.  I attempted to drive to grocery store and ended up at a tool store and didn?t know why I was there.   It took a very long time for complete cognitive function to return so that I could create lectures and teach as a lecturer at IU.   My dependents would have had to call on my behalf but they did not.  I was not even able to communicate with my courses to let them know there was a problem as I normally would.
developed a skin condition. It feels like a sun burn and affects his arms, hands, and face.; Sometimes it itches and it usually happens after he eats; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS ( developed a skin condition. It feels like a sun burn and affects his arms, hands, and face.), PRURITUS (Sometimes it itches and it usually happens after he eats) and PAIN IN EXTREMITY (sore arm) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A20A and 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Diabetes.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (sore arm). On an unknown date, the patient experienced RASH ERYTHEMATOUS ( developed a skin condition. It feels like a sun burn and affects his arms, hands, and face.) and PRURITUS (Sometimes it itches and it usually happens after he eats). At the time of the report, RASH ERYTHEMATOUS ( developed a skin condition. It feels like a sun burn and affects his arms, hands, and face.), PRURITUS (Sometimes it itches and it usually happens after he eats) and PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) Normal.         Patient could not remember the concomitant medications.  No treatment medications were reported.   This case was linked to MOD-2021-014619 (Patient Link).
This spontaneous report as received from a registered nurse refers to a 4 months old female patient. Pertinent medical history, drug reactions and allergies were none. Approximately on an unspecified date in September 2012 (reported as a couple of weeks ago), the patient was vaccinated with ROTATEQ. Lot number and the dosing details were not reported. Secondary suspect vaccinated included HepB vaccine (manufacturer was not specified). Concomitantly the patient received PREVNAR and PENTACEL. On an unspecified date in 2012, the patient developed rash on lower extremities and buttocks and was seen in allergist office. The patient had sought medical attention for the same. No treatment information was reported. The outcome of the event rash on lower extremities and buttocks was reported as recovering/resolving. Additional information has been requested.
SEVERE RASH ALL OVER FACE, CHEST, BILATERAL ARMS AND LEGS, PATIENT COMPLAINS OF A BURNING SENSATION
Site: Itching at Injection Site-Mild, Systemic: Allergic: Itch Generalized-Mild, Systemic: Allergic: Rash Generalized-Mild, Systemic: discomfort-Mild, Additional Details: PT says he has had hives, itching, and still has some discomfort following initial doses of Moderna vaccine
Patient developed swelling and redness on front and sides of left thigh extending to knee. The area was warm to the touch. Patient noted to have a slight limp with walking.
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A female patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. Medical history and concomitant medications not reported. The patient experienced herpes virus infection (since the COVID-19 vaccination, noticed an increase in herpes outbreaks), with outcome of unknown. The batch/lot number for BNT162B2 not provided and will be requested during follow-up.
Swelling lymth node left area neck; body ache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body ache) and LYMPHADENOPATHY (Swelling lymth node left area neck) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Apr-2021, the patient experienced PAIN (body ache). On 28-Apr-2021, the patient experienced LYMPHADENOPATHY (Swelling lymth node left area neck). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 2 doses. At the time of the report, PAIN (body ache) and LYMPHADENOPATHY (Swelling lymth node left area neck) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.
Within 10 minutes of receiving vaccine, caregiver developed tachycardia, lightheadedness, chest tightness, and a headache, was taken to the ER and monitored and released.
Hospitalization: 1/12/2023 - 1/16/2023  Presentation to the ED: shortness of breath and defibrillator fire.  COVID + date: 1/2/23 & 1/16/23.  Treatment: none.  Discharge to: HOME.  029K20A 2/17/2021 047A21A 3/19/2021 027H21B 11/23/2021
"Covid Arm" ...Red, itchy, very hot patch on left arm about 8 days after shot...lasted 3-4 days I experienced something similar as is discussed in this article